Cosmo N.V. (SWX:CMHC)
58.30
+0.60 (1.04%)
Aug 24, 2026, 5:31 PM CET
Cosmo Revenue
Cosmo had revenue of 50.24M EUR in the half year ending June 30, 2026, a decrease of -63.13%. This brings the company's revenue in the last twelve months to 102.69M, down -43.66% year-over-year. In the year 2025, Cosmo had annual revenue of 104.17M, down -60.95%.
Revenue (ttm)
102.69M EUR
Revenue Growth
-43.66%
P/S Ratio
10.46
Revenue / Employee
281.34K EUR
Employees
365
Market Cap
991.89M CHF
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 104.17M | -162.61M | -60.95% |
| Dec 31, 2024 | 266.79M | 174.01M | 187.55% |
| Dec 31, 2023 | 92.78M | -9.31M | -9.12% |
| Dec 31, 2022 | 102.09M | 37.02M | 56.88% |
| Dec 31, 2021 | 65.07M | 4.13M | 6.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ARYZTA AG | 2.03B |
| naturenergie holding AG | 1.33B |
| Aevis Victoria | 1.04B |
| Sensirion Holding AG | 336.83M |
| Medartis Holding AG | 307.05M |
| Basilea Pharmaceutica AG | 247.42M |
| Kuros Biosciences AG | 141.35M |
| Zug Estates Holding AG | 91.26M |
Cosmo News
- 7 weeks ago - Invitation to Cosmo's Half-Year 2026 Financial Results Webcast on 23 July 2026 - Newsfile Corp
- 2 months ago - Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark - Newsfile Corp
- 4 months ago - Cosmo price target raised to CHF 160 from CHF 130 at H.C. Wainwright - TheFly